Omnicell OMCL
- Market cap
- $1.7B
- PE
- 44.9×
- 10y median 74.0×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 1.4×
- EV/EBIT
- 27.9×
- Revenue, 12 months
- $1.2B
- +8% on a year ago
- Net margin
- 3.1%
- Free cash flow yield
- 8.3%
Omnicell trades at 44.9× trailing earnings, cheaper than 93% of the last ten years. Revenue was $1.2B over the last twelve months, up 8% on a year earlier with a 3% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $298.7M−14% | $258.8M−13% | $246.2M−15% | $276.8M−7% | $282.4M−5% | $306.9M+19% | $269.7M+10% | $290.6M+5% | $310.6M+10% | $314M+2% | $309.9M+15% | $312.2M+7% | |
| Cost of revenue | $166.7M−12% | $153.4M−13% | $153.5M−7% | $162.4M−1% | $160.2M−4% | $165.1M+8% | $158.7M+3% | $162.9M+0% | $176.1M+10% | $183.7M+11% | $169.5M+7% | $159.3M−2% |
| Gross profit | $132M−17% | $105.4M−13% | $92.6M−26% | $114.4M−15% | $122.3M−7% | $141.8M+35% | $110.9M+20% | $127.7M+12% | $134.5M+10% | $130.3M−8% | $140.4M+27% | $152.9M+20% |
| R&D | $24.3M−4% | $26.8M−6% | $22.1M−4% | $21.1M−9% | $21.2M−13% | $26M−3% | $20.5M−7% | $21.6M+2% | $24M+13% | $22.6M−13% | $21.5M+5% | $20.3M−6% |
| SG&A | $104M−10% | $102M−23% | $92.4M−26% | $90M−13% | $94.5M−9% | $103.3M+1% | $102M+10% | $98M+9% | $102.2M+8% | $107.4M+4% | $102M+0% | $100.2M+2% |
| $3.7M−80% | −$23.4M−39% | −$21.8M−5% | $3.2M−58% | $6.6M+77% | $12.4M | −$11.6M−47% | $8.1M+152% | $8.2M+26% | $415K−97% | $16.9M | $32.4M+300% | |
| Interest expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pre-tax income | $7.4M−57% | −$18.5M−48% | −$17.8M−16% | $8.2M−33% | $11.6M+58% | $23.6M | −$9.5M−47% | $10.5M+28% | $9.7M−17% | $699K−97% | $16.9M | $33.8M+224% |
| $1.8M+237% | −$4.1M−42% | −$2.2M−65% | $4.5M−49% | $3M+64% | $7.8M | −$2.5M+16% | $4.8M+8% | $4.2M+42% | $2.7M−65% | $5.5M | $9.5M+98% | |
| Net income | $5.6M−67% | −$14.4M−49% | −$15.7M+5% | $3.7M+8% | $8.6M+55% | $15.8M | −$7M−55% | $5.6M+51% | $5.5M−37% | −$2M | $11.4M | $24.3M+331% |
| $0.12−68% | −$0.32−50% | −$0.34+3% | $0.08+0% | $0.19+58% | $0.34 | −$0.15−56% | $0.12+50% | $0.12−37% | −$0.05 | $0.25 | $0.52+333% | |
| 45.6M−1% | 45.5M+2% | 45.7M+2% | 46M+1% | 46.4M+2% | 46.6M+2% | 46.6M+2% | 47M+2% | 45.9M−1% | 45M−3% | 45.9M−1% | 46.3M−2% |
Net income: 16 periods, Q3 FY10 to Q3 FY14: not printed by the filing, worked out from its own lines.
EPS, diluted: 16 periods, Q4 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 11 periods, Q4 FY10 to Q4 FY21: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY17 and Q4 FY24: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution. 3 periods, Q4 FY22 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Computer Hardware nearest Omnicell's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| OMCLOmnicell | $1.7B | 44.9× | 74.0× | 1.4× | +8% | 3.1% | |
| CRSRCorsair Gaming | $1.5B | 44.3× | 21.3× | 1.0× | +3% | 2.5% | |
| DBDDIEBOLD NIXDORF | $2.3B | 22.6× | 28.9× | 0.6× | +5% | 2.9% | |
| PBIPitney Bowes | $2.4B | 14.2× | 15.2× | 1.3× | −5% | 10.0% | |
| VYXNCR Voyix | $1.2B | 21.0× | 18.5× | 0.5× | −5% | 3.0% | |
| NATLNCR Atleos | $3.5B | 18.3× | 20.6× | 0.8× | +4% | 4.4% | |
| MITKMitek Systems | $841.1M | 39.7× | 69.9× | 4.3× | +11% | 11.4% | |
| IMMRImmersion | $236.4M | 21.6× | 7.4× | 0.1× | +4% | 0.6% | |
| LOGILogitech International | $15.7B | 20.1× | 24.6× | 3.2× | +7% | 16.3% | |
| Peer median | $1.9B | 21.3× | 21.0× | 0.9× | +4% | 3.7% |
More on Omnicell
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #2of 12Computer hardware stocks cheapest against their own PE history
- #7of 17Computer hardware stocks with the highest free cash flow yield
- #7of 16Computer hardware stocks with the fastest earnings growth
Its groups
About
- Industry
- Computer Hardware
- Sector
- Technology
Valuation data, not investment advice. Prices as of .